The Kansas City Chiefs are in a dogfight with their hated rival, the Cincinnati Bengals, but the Chiefs took the lead in the third quarter in the funniest way.

Emicizumab is under clinical development by Chugai Pharmaceutical and currently in Phase I for Von Willebrand Disease (vWD).

Keaton has ended up on as many worst-dressed lists as best-dressed ones, something she admirably embraces. One chapter, titled “WRONG WRONG WRONG WRONG WRONG,” is a roundup of her worst looks, with ...

Sponsored advertising by The Oasis at Death Valley. More: <a href=" ...

A Hamilton County judge recently granted a temporary injunction on Ohio’s FDA label restriction on abortion medication, meaning doctors can prescribe the drug mifepristone off-label, a common ...

If the “new spirit of capitalism” analyzed by Luc Boltanski and Ève Chiapello had to be embodied in any one location, an ...

Managing deadlines while collaborating with physicians can be a complex task due to their demanding schedules and critical responsibilities. To ensure successful collaboration, it's important to ...

BMN 370 for the treatment of von Willebrand Disease (vWD) has the potential to normalize bleeding events, based on results from a vWD preclinical model, and is designed to be delivered with a ...

The Von Willebrand Disease (vWD) drugs in development market research report provides comprehensive information on the therapeutics under development for Von Willebrand Disease (vWD), complete with ...

Scrappy. That's the best way to describe United's win on Saturday. An undeniable fact, however, is that you get the same three points from a scrappy win as you do from a free flowing, blow the ...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) hosted an Investor Day earlier today, where President and Chief Executive Officer Alexander Hardy and other members ...